Enter Passcode wrote:
說實話
如果政府進，我會打
我姊夫這次回去，會在那邊打
個人積分：59265分
文章編號：80799865
個人積分：323分
文章編號：80799936
Moderna Announces Publication of Results from the Pivotal Phase 3 Trial of the Moderna COVID-19 Vaccine in The New England Journal of Medicine
December 31, 2020
===========
moderna 在宣稱三期試驗結果在文獻刊載之前, 美國FDA就通過緊急授權了
目前所有的疫苗獲得的都是緊急授權啦
只要評估利大於弊就過了
之後的上市後再評估也是重頭戲
=========================
至於對岸的SINOVAC公司的CoronaVac
新聞2月5日已經發表三期結果
https://www.businesswire.com/news/home/20210205005496/en/
As of December 16, 2020, there were 12,396 health workers over 18 years old enrolled. A total of 253 positive cases were collected during the observation period. After 14 days following vaccination with 2 doses of vaccine following a 0, 14 day schedule, the efficacy rate against diseases caused by COVID-19 was 50.65% for all cases, 83.70% for cases requiring medical treatment, and 100.00% for hospitalized, severe, and fatal cases.
There are two stages of the phase III clinical trial in Turkey. Participants comprised health care workers in the first stage (K-1) and the general population in the second stage (K-2), with all participants ranging from 18 to 59 years old. As of December 23, 2020, there were 918 participants enrolled in K-1 and 6,453 participants in K-2, for a total of 7,371 participants. Among them, 1,322 participants completed the two-dose vaccination and entered the 14-day observation period after receiving the second dose of the vaccination. Based on an analysis of 29 cases, the efficacy rate for COVID-19 prevention was 91.25% after 14 days following the two-dose vaccination, in adherence with the 0, 14 day schedule.
在巴西場,減少醫療照護83%與減少死亡效果100%似乎不錯,不過輕症只有50趴預防效果
在土耳其場,完成二劑人數只有一千三百多人,但是效果可以達到91%也不錯
再來就是等三期文獻發表
==============
現在疫苗是賣方市場
要搶哪個,何時開搶,搶的到哪個需要大智慧
沒有疫苗要解除國境封鎖恐怕很難
個人積分：5086分
文章編號：80801612
個人積分：323分
文章編號：80802046
個人積分：294分
文章編號：80802292
個人積分：2975分
文章編號：80802757
個人積分：12分
文章編號：80803350
個人積分：2975分
文章編號：80803388
閱
個人積分：135分
文章編號：80803847
個人積分：2975分
文章編號：80803869
